Impact of TKIs post–allogeneic hematopoietic cell transplantation in Philadelphia chromosome–positive ALL
Author:
Affiliation:
1. Department of Stem Cell Transplantation and Cellular Therapy and
2. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
Abstract
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/136/15/1786/1760629/bloodbld2019004685.pdf
Reference14 articles.
1. Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia;Abou Dalle;Curr Treat Options Oncol,2019
2. Relapse Prevention with Tyrosine Kinase Inhibitors after Allogeneic Transplantation for Ph+ ALL, A Systematic Review;Warraich;Biol Blood Marrow Transplant,2020
3. Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: a position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation;Giebel;Cancer,2016
4. Allogeneic transplantation for patients with Philadelphia chromosome positive acute lymphoblastic leukemia: is it imperative in the tyrosine kinase inhibitor era?;Litzow;Best Pract Res Clin Haematol,2018
5. Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia;Carpenter;Blood,2007
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. 移植後維持療法の現在と将来展望;Japanese Journal of Transplantation and Cellular Therapy;2024
2. How to Manage Philadelphia-Positive Acute Lymphoblastic Leukemia in Resource-Constrained Settings;Cancers;2023-12-10
3. Hematopoietic Transplantation and Cellular Therapy in Acute Lymphoblastic Leukemia;Cancer Consult;2023-11-18
4. SOHO State of the Art Updates and Next Questions | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in Adults: Therapeutic Options and Challenges in 2023;Clinical Lymphoma Myeloma and Leukemia;2023-11
5. CAR T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia;Journal of Clinical Medicine;2023-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3